PRR7-AS1: A Potential Drug Target and Biomarker (G340037)

Target Name: PRR7-AS1

NCBI ID: G340037

PRR7-AS1

Other Name(s): PRR7-AS1 variant 1 | PRR7 antisense RNA 1

PRR7-AS1: A Potential Drug Target and Biomarker

PRR7-AS1, also known as PRR7-AS1 variant 1, is a protein that is expressed in the human placenta and has been identified as a potential drug target or biomarker. The protein is a member of the PRR7 family, which is known for its role in cell signaling and is expressed in various tissues and organs, including the brain, heart, and blood vessels.

The PRR7-AS1 protein is unique due to its structure and expression pattern. It has a unique N-terminus that is rich in amino acids, which is known as a hypervariable region (HVR). This HVR is highly conserved across different species and is thought to play a role in the protein's stability and stability interactions. Additionally, PRR7-AS1 has a unique C-terminus that is rich in cysteine residues, which may be involved in the protein's stability or interactions with other proteins.

PRR7-AS1 is also expressed in various tissues and organs, including the brain, where it has been shown to be expressed in the postsynaptic density matrix (PDM) of neurons and may play a role in synaptic plasticity. In addition, PRR7-AS1 is also expressed in the heart and has been shown to be involved in cardiac function and may be a potential drug target for cardiovascular disease.

The potential drug target status of PRR7-AS1 is supported by several studies. First, there is evidence that PRR7-AS1 is a validated drug target, as several drugs have been shown to interact with this protein. For example, inhibitors of the PRR7-AS1 gene have been shown to protect against neurotoxicity in animal models of neurodegenerative diseases, including Alzheimer's disease. Additionally, PRR7-AS1 has been shown to be involved in several diseases, including cancer, as it has been shown to be involved in the development and progression of several types of cancer.

In addition to its potential drug target status, PRR7-AS1 also has potential as a biomarker. The protein is expressed in various tissues and organs and can be used as a protein biomarker for disease diagnosis and monitoring. For example, PRR7-AS1 has been used as a biomarker for cancer, as it has been shown to be expressed in the brains of patients with cancer and may be a useful indicator of disease progression. Additionally, PRR7-AS1 has been shown to be expressed in the blood vessels of patients with cardiovascular disease and may be a useful biomarker for disease monitoring in these patients.

Overall, PRR7-AS1 is a unique and highly conserved protein that has the potential to be a drug target or biomarker. Further research is needed to fully understand its role in disease and to develop effective treatments.

Protein Name: PRR7 Antisense RNA 1

The "PRR7-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRR7-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets